イノバセル株式会社 (504A) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-08-12 | — | (Delayed) Quarterly Update_Q2 FY2026 | |
| 2026-08-06 | — | Patient Enrollment Status of the ICEF15 Multi-Regional Phase III Clinical Trial (Fidelia) and Completion of Patient Recruitment in Japan and Europe | |
| 2026-08-06 | Earnings Release | Summary of Consolidated Financial Results for the Half Year Ended June 2026 (Based on Japanese GAAP, QUICK TRANSLATION) | |
| 2026-07-23 | — | Announcement Regarding the Execution of a Product Commercialization Agreement with EVERSANA Life Science Services, LLC for the U.S. Market |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.